GHALIE RICHARD G 4

4 · MEI Pharma, Inc. · Filed May 5, 2021

Form 4

Period: 2021-05-03

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2021-05-03+75,000→ 75,000 total
Exercise: $3.55Exp: 2031-05-03→ Common Stock (75,000 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $3.49Exp: 2030-07-02→ Common Stock (150,000 underlying)
650,000
Stock Option (Right to Buy)
Exercise: $2.88Exp: 2027-07-07→ Common Stock (65,000 underlying)
220,000
Stock Option (Right to Buy)
Exercise: $4.28Exp: 2028-07-12→ Common Stock (130,000 underlying)
350,000
Stock Option (Right to Buy)
Exercise: $2.52Exp: 2029-07-01→ Common Stock (150,000 underlying)
500,000
Stock Option (Right to Buy)
Exercise: $1.21Exp: 2026-03-07→ Common Stock (130,000 underlying)
130,000
Stock Option (Right to Buy)
Exercise: $1.38Exp: 2026-07-14→ Common Stock (25,000 underlying)
155,000

Footnotes (6)

[F1]1/4th of shares vest one-year from 5/03/2021, with the remaining balance of shares vesting in 36 equal amounts over three years.
[F2]All options are currently exercisable.
[F3]1/4th of shares vest one-year from July 7, 2017, with the remaining balance of shares vesting in 36 equal amounts over three years.
[F4]1/4th of shares vest one-year from July 12, 2018, with the remaining balance of shares vesting in 36 equal amounts over three years.
[F5]1/4th of shares vest one-year from July 1, 2019, with the remaining balance of shares vesting in 36 equal amounts over three years.
[F6]1/4th of shares vest one-year from July 2, 2020, with the remaining balance of shares vesting in 36 equal amounts over three years.

Documents

1 file